Corporate Social Responsibility

The development of vaccines and antibodies against infectious diseases is not only an attractive business opportunity, but also a contribution to society that provides significant value beyond commercial standards. Corporate Social Responsibility at Intercell is anchored at the Management Board level. Ethical responsibility is leading Intercell to engage e.g. in the development of vaccines for Tuberculosis, Pneumococcal infections, Malaria, and Japanese Encephalitis in endemic countries. Special collaborations are set up with PATH (an international organization that improves the health of people around the world) and Aeras Global Tuberculosis Vaccine Foundation, to ensure future availability and accessibility of possible vaccines in the developing world.

The more successful we are in discovering, developing, and manufacturing new vaccines, the greater the benefits we can offer to patients, partners, shareholders, and other stakeholders. We offer novel vaccine and antibody candidates that address unmet medical needs.

In order to be recognized as an innovative and trustworthy company, Intercell fosters a culture where associates are expected to behave ethically and lawfully. Intercell’s core corporate values can be characterized by goal orientation at all levels of the company, trust in our Management and in each other as individuals and teams, and a sincere dedication to innovation in order to overcome unmet medical needs.